PMID- 29166703 OWN - NLM STAT- MEDLINE DCOM- 20180827 LR - 20240314 IS - 1540-8183 (Electronic) IS - 0896-4327 (Print) IS - 0896-4327 (Linking) VI - 31 IP - 2 DP - 2018 Apr TI - In-hospital outcomes in invasively managed acute myocardial infarction patients who receive morphine. PG - 150-158 LID - 10.1111/joic.12464 [doi] AB - OBJECTIVE: We aimed to analyze the association between morphine and in-hospital outcomes in invasively managed ST elevation myocardial infarction (STEMI) and non-ST elevation acute coronary syndrome (NSTE-ACS) patients. BACKGROUND: Morphine is commonly used for analgesia in the setting of acute coronary syndromes (ACS); however, recently its utility in ACS has come under closer scrutiny. METHODS: We identified all STEMI and NSTE-ACS patients undergoing coronary angiogram +/- percutaneous intervention between January 2009 and July 2016 in our center and recorded patient characteristics and inpatient outcomes. RESULTS: Overall, 3027 patients were examined. Overall, STEMI patients who received morphine had no difference in in-hospital mortality [4.18% vs. 7.54%, odds ratio (OR): 0.36, P = 0.19], infarct size (mean troponin level 0.75 ng/mL vs. 1.29 ng/mL, P = 0.32) or length of hospital stay (P = 0.61). The NSTE-ACS patients who received morphine had a longer hospital stay (mean 6.58 days vs. 4.78 days, P < 0.0001) and larger infarct size (mean troponin 1.16 ng/mL vs. 0.90 ng/mL, P = 0.02). Comparing matched patients, the use of morphine was associated with larger infarct size (mean troponin 1.14 +/- 1.92 ng/mL vs. 0.83 +/- 1.49 ng/mL, P = 0.01), longer hospital stay (6.5 +/- 6.82 days vs. 4.89 +/- 5.36 days, P = 0.004) and a trend towards increased mortality (5% vs. 2%, OR: 2.55, P = 0.06) in NSTE-ACS patients but morphine did not affect outcomes in the propensity matched STEMI patients. CONCLUSION: In a large retrospective study, morphine was associated with larger infarct size, a longer hospital stay and a trend towards increased mortality in invasively managed NSTE-ACS patients even after adjustment for clinical characteristics. CI - (c) 2017, Wiley Periodicals, Inc. FAU - McCarthy, Cian P AU - McCarthy CP AUID- ORCID: 0000-0003-4944-0034 AD - Department of Medicine, Massachusetts General Hospital, Boston, MA. FAU - Bhambhani, Vijeta AU - Bhambhani V AD - Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA. FAU - Pomerantsev, Eugene AU - Pomerantsev E AD - Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA. FAU - Wasfy, Jason H AU - Wasfy JH AD - Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA. LA - eng GR - KL2 TR001100/TR/NCATS NIH HHS/United States GR - UL1 TR001102/TR/NCATS NIH HHS/United States PT - Journal Article DEP - 20171122 PL - United States TA - J Interv Cardiol JT - Journal of interventional cardiology JID - 8907826 RN - 0 (Analgesics, Opioid) RN - 76I7G6D29C (Morphine) SB - IM MH - *Acute Coronary Syndrome/diagnosis/drug therapy/mortality/surgery MH - Aged MH - Analgesics, Opioid/administration & dosage/adverse effects MH - Female MH - Hospital Mortality MH - Humans MH - Length of Stay MH - Male MH - Middle Aged MH - *Morphine/administration & dosage/adverse effects MH - Odds Ratio MH - Outcome and Process Assessment, Health Care MH - *Percutaneous Coronary Intervention/adverse effects/methods MH - Retrospective Studies MH - *ST Elevation Myocardial Infarction/diagnosis/drug therapy/mortality/surgery MH - United States/epidemiology PMC - PMC5897161 MID - NIHMS918036 OTO - NOTNLM OT - NTE-ACS OT - STEMI OT - morphine EDAT- 2017/11/23 06:00 MHDA- 2018/08/28 06:00 PMCR- 2019/04/01 CRDT- 2017/11/23 06:00 PHST- 2017/06/12 00:00 [received] PHST- 2017/10/13 00:00 [revised] PHST- 2017/10/17 00:00 [accepted] PHST- 2017/11/23 06:00 [pubmed] PHST- 2018/08/28 06:00 [medline] PHST- 2017/11/23 06:00 [entrez] PHST- 2019/04/01 00:00 [pmc-release] AID - 10.1111/joic.12464 [doi] PST - ppublish SO - J Interv Cardiol. 2018 Apr;31(2):150-158. doi: 10.1111/joic.12464. Epub 2017 Nov 22.